Archive for 'Tag Archives: 'Partnering''

ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis

ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis

Belgian-based ImCyse, a spin-off originally from the Catholic University of Leuven (KUL), but now established at both KUL and University of Liège (ULg), was founded in July 2010 by Prof. Jean-Marie Saint-Remy to valorize discoveries made [...]

Coris BioConcept partnership with American company Covaris leads to €500,000 in combined funding through grants and investments

Coris BioConcept partnership with American company Covaris leads to €500,000 in combined funding through grants and investments

Coris BioConcept (Gembloux, Belgium), a SME specialized in the development of diagnostic kits, has recently signed a partnership with Covaris (Massachusetts, USA), and is investing €100K alongside a DG06 grant of €150K in combined funding from [...]

Belgo-American partnership between Promethera Biosciences and EMD Millipore to develop pre-clinical liver pharmaco-toxicological testing assay

Belgo-American partnership between Promethera Biosciences and EMD Millipore to develop pre-clinical liver pharmaco-toxicological testing assay

  The recent Belgo-American partnership between Promethera® Biosciences (Mont-Saint-Guibert, Belgium), and EMD Millipore (Billerica, MA USA) to develop an improved ready-to-use microfluidic perfusion liver assay, is BioWin’s latest ‘Success Story’. The initiative behind this strategic project [...]

Aepodia and Bio-Modeling Systems sign a strategic R&D collaboration to decipher the Fibromyalgia & chronic facial pain mechanisms

Aepodia and Bio-Modeling Systems sign a strategic R&D collaboration to decipher the Fibromyalgia & chronic facial pain mechanisms

Aepodia (Louvain-la-Neuve, Belgium) and Bio-Modeling Systems (BMSystems, Paris, France) have launched an innovative research program aimed to better understand, diagnose and treat severe pains. Opening new avenues for pain diagnosis and treatment By combining their expertise [...]

Rosellini Scientific Benelux SA Joins Walloon Region Consortium to Help Develop Implant System for Glaucoma Treatment

Rosellini Scientific Benelux SA Joins Walloon Region Consortium to Help Develop Implant System for Glaucoma Treatment

An exciting new medtech player in Belgium’s Walloon Region – Rosellini Scientific Benelux SA (RSB) – joins the consortium to develop a novel implant system for treating and monitoring glaucoma. The 4-partner consortium, led by iSTAR [...]

Further collaborations: UCB (Belgium) and Oncodesign (France) combine strengths in neurology

Further collaborations: UCB (Belgium) and Oncodesign (France) combine strengths in neurology

A recent collaboration between Belgian pharmaceutical group UCB and France-based Oncodesign aims at the development of innovative therapeutic treatments in neurodegenerative diseases. Within the framework of this collaboration, Oncodesign will apply its Nanocyclix technology* to identify next generation kinase inhibitors [...]

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

GlaxoSmithKline and Texas A&M approval to establish influenza vaccine facility

In March, GlaxoSmithKline(GSK) and the Texas A&M University System (TAMUS) announced the U.S. Department of Health and Human Services (DHHS) had approved the establishment of a $91 million (€70.3 million) influenza-vaccine manufacturing facility as the pillar [...]

Public-private partnership leads to unique Walloon Cell Therapy Platform

Public-private partnership leads to unique Walloon Cell Therapy Platform

As the foundation for the new Walloon Cell Therapy Platform* begins to set in Gosselies, Belgium an exciting new development for Wallonia gets underway. The platform, unique in this sector, will provide Wallonia with a new [...]

UCB (Braine-l’Alleud, Belgium) and FivePrime Therapeutics (San Francisco, CA.) in collaboration for the discovery of innovative biologic targets and therapeutics

UCB (Braine-l’Alleud, Belgium) and FivePrime Therapeutics (San Francisco, CA.) in collaboration for the discovery of innovative biologic targets and therapeutics

UCB and Five Prime Therapeutics have recently entered a strategic collaboration for the discovery of innovative biologics targets and therapeutics for fibrosis-related inflammatory diseases and central nervous system (CNS) disorders.  UCB, located in the Wallonia region [...]

Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment

Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment

Artialis(Liège) and Tilman(Baillonville), two Wallonia-based biotech companies specialized in joint disorders and medicinal plant therapy respectively, through combined efforts are making a name for themeselves with effective “natural” treatment of joint disorders. Everyone knows joints can [...]